CNBX Pharmaceuticals Inc. Liquidation Value
CNBX
Other
Cash & Equivalents
$12,154
As of 2026-02-28
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $12,154
Total Obligations: -$2.55M
$-2.54M
Per share: $-0.00
Period: 2026-02-28
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $12,154
AR: $0
Total Obligations: -$2.55M
$-2.54M
Per share: $-0.00
Period: 2026-02-28
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $12,154
AR: $0
Inventory: $0
Total Obligations: -$2.55M
$-2.54M
Per share: $-0.00
Period: 2026-02-28
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-2.54M | $-0.00 |
| Liquid Liquidation Value | $-2.54M | $-0.00 |
| Operating Liquidation Value | $-2.54M | $-0.00 |
Key Components (as of 2026-02-28)
| Cash & Equivalents | $12,154 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $2.55M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 1.13B |
Explore all 56 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2026-02-28 | $12,154 | N/A | N/A | N/A | $2.55M | N/A | N/A | N/A |
| 2025-11-30 | $7,703 | N/A | N/A | N/A | $2.58M | N/A | N/A | N/A |
| 2025-08-31 | $15,111 | N/A | N/A | N/A | $2.51M | N/A | N/A | N/A |
| 2025-05-31 | $13,648 | N/A | N/A | N/A | $2.56M | N/A | N/A | N/A |
| 2025-02-28 | $45,675 | N/A | N/A | N/A | $2.62M | N/A | N/A | N/A |
| 2024-11-30 | $17,339 | N/A | N/A | N/A | $2.54M | N/A | N/A | N/A |
| 2024-08-31 | $26,416 | N/A | N/A | N/A | $2.51M | N/A | N/A | N/A |
| 2024-05-31 | $73,406 | N/A | N/A | N/A | $2.53M | N/A | N/A | N/A |
▼ Community Notes